Doku mühendisliği için ıslak eğrilmiş PCL iskeleler.

Scaffolds produced for tissue engineering applications are promising alternatives to be used in healing and regeneration of injured tissues and organs. In this study, fibrous poly(ε-caprolactone) (PCL) scaffolds were prepared by wet spinning technique and modified by addition of β-tricalcium phosphate (β-TCP) and by immobilizing gelatin onto fibers. Meanwhile, gelatin microspheres carrying Ceftriaxone sodium (CS), a model antibiotic, were added onto the scaffolds and antimicrobial activity of CS was investigated against Escherichia coli (E. coli), chosen as a model gram-negative bacterium. β-TCP and gelatin were added to enhance mechanical properties while directing the scaffold towards osteogenic infrastructure; and to increase hydrophilicity by activating cell attachment via protein molecules, respectively. Modifications with β-TCP and gelatin enhanced compression modulus about 70%, and attachment of Saos-2 cells for 60%, respectively. Presence and release of CS demonstrated effective antimicrobial activity against E. coli. Bioactive scaffolds prepared in this study can be good candidates for bone tissue engineering applications. M.S. - Master of Scienc

Preparation and characterization of poly(epsilon-caprolactone) scaffolds modified with cell-loaded fibrin gel

Poly(epsilon-caprolactone) (PCL) is one of the most commonly used polymers in the production of tissue engineered scaffolds for hard tissue treatments. Incorporation of cells into these scaffolds significantly enhances the healing rate of the tissue. In this study, PCL scaffolds were prepared by wet spinning technique and modified by addition of fibrinogen in order to form a fibrin network between the PCL fibers. By this way, scaffolds would have micro and nanofibers in their structures. Drying of the wet spun constructs was achieved by application of ethanol dehydration or freeze drying techniques. Fibrinogen solutions (as low: 2 mg/mL; or high: 10 mg/mL concentrations) were added onto the scaffolds and fibrin formation was achieved via fibrinogen crosslinking. Results showed that ethanol dehydration led to film-like coating on the fibers while freeze-drying led to nanofiber bridges between PCL fibers establishing an interconnected web in the structure. Mechanical properties of the scaffolds were improved in the presence of the fibrin net. After the seeding of Saos-2 cells, higher attachment and homogeneous distribution of the cells was achieved on the samples modified with high concentration of fibrinogen. These scaffolds can be good candidates for the treatment of problematic bone defects

PCL and PCL-based materials in biomedical applications

Biodegradable polymers have met with an increasing demand in medical usage over the last decades. One of such polymers is poly(epsilon-caprolactone) (PCL), which is a polyester that has been widely used in tissue engineering field for its availability, relatively inexpensive price and suitability for modification. Its chemical and biological properties, physicochemical state, degradability and mechanical strength can be adjusted, and therefore, it can be used under harsh mechanical, physical and chemical conditions without significant loss of its properties. Degradation time of PCL is quite long, thus it is used mainly in the replacement of hard tissues in the body where healing also takes an extended period of time. It is also used at load-bearing tissues of the body by enhancing its stiffness. However, due to its tailorability, use of PCL is not restricted to one type of tissue and it can be extended to engineering of soft tissues by decreasing its molecular weight and degradation time. This review outlines the basic properties of PCL, its composites, blends and copolymers. We report on various techniques for the production of different forms, and provide examples of medical applications such as tissue engineering and drug delivery systems covering the studies performed in the last decades

PCL-TCP wet spun scaffolds carrying antibiotic-loaded microspheres for bone tissue engineering

Scaffolds produced for tissue engineering applications are proven to be promising alternatives to be used in healing and regeneration of injured tissues and organs. In this study, porous and fibrous poly(epsilon-caprolactone) (PCL) scaffolds were prepared by wet spinning technique and modified by addition of tricalcium phosphate (TCP) and by immobilizing gelatin onto fibers. Meanwhile, gelatin microspheres carrying Ceftriaxone sodium (CS), a model antibiotic, were added onto the scaffolds and antimicrobial activity of CS was investigated against Escherichia coli (E. coli), a model gram-negative bacterium. TCP and gelatin were added to enhance mechanical properties while directing the scaffold towards osteogenic infrastructure and to increase hydrophilicity by activating cell attachment via protein molecules, respectively. Modifications with TCP and gelatin enhanced thecompression modulus byabout 70%, and attachment of Saos-2 cells by60%, respectively. Release of the antibiotic demonstrated effective antimicrobial activity against E. coli. The bioactive scaffolds wereshown to be good candidates for bone tissue engineering applications

Surface modified multi-functional PCL/TCP fibrous scaffolds

Porous and fibrous scaffolds prepared using various methods are essential components of tissue engineering. Poly(ε-caprolactone) (PCL), due to its biocompatibility and mechanical properties, is one of the most desirable polymers in scaffold preparation for bone tissue engineering applications, and there are many studies on modification of PCL to enhance its biocompatibility. In this study, porous and fibrous scaffolds of PCL containing TCP were prepared by wet spinning and gelatin was immobilized onto it to enhance cell attachment on the surface. In order to increase the local antimicrobial agent delivery to the application site, gelatin microvesicles carrying a model antibiotic were adhered on the scaffold surface. Scaffolds were incubated with human osteosarcoma cells Saos-2 to study its biocompatibility and the antimicrobial effect on E. coli